Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Paralysis, Legs

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Paralysis, Legs in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Follis, FM1
Blisard, KS1
Varvitsiotis, PS1
Pett, SB1
Temes, RT1
Wernly, JA1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Paralysis, Legs

ArticleYear
Selective protection of gray and white matter during spinal cord ischemic injury.
    The Annals of thoracic surgery, 1999, Volume: 67, Issue:5

    Topics: Animals; Brain; Disease Models, Animal; Evaluation Studies as Topic; Excitatory Amino Acid Antagonis

1999